Episode 9: Should We Be Getting Full Body MRIs?

Episode 15: Do Fitness Tracking Watches & Rings Actually Make Us Healthier?

In this episode, we explore the hype and reality behind wearables like Oura Rings, Apple Watches, Fitbits, and other fitness trackers, using real patient stories to frame the conversation. We share what the data can and can’t tell you, how accuracy varies across metrics, and why “more data” doesn’t always mean better health outcomes. We also discuss why these devices are so popular, the motivations and fears they tap into, and the potential downsides—like anxiety, perfectionism, and increased healthcare utilization. We close with how we think about these tools in clinic and how to decide whether a wearable is truly helping you. 00:00 Podcast mission 01:25 Patient stories 03:05 Wearables big claims 05:35 Why wearables took off 11:04 Nugget of truth 13:54 Accuracy and impact 14:58 Step counting science 18:24 Apple Heart Study 23:08 Heart rate variability 27:19 HRV Norms Myth 27:34 Wearables and Heart Health 30:34 Sleep Tracking Accuracy 32:30 Sleep Apnea Screening 34:40 Patient Case Sleep Apnea 37:21 Psychological Harms 40:04 Data Overload and OCD 43:27 Healthcare Utilization Risks 46:38 Trusting Symptoms Over Data 51:24 Costs and Hidden Tradeoffs 52:41 Talking to Patients 55:50 Wrap Up and Disclaimer 📖 Read the full episode summary, sources, and resources on our Substack:  👉www.theantisocialdoctors.com

Episode 14: Can A Blood Test Really Detect 50+ Cancers?

In this episode, we discuss the viral rise of multi-cancer early detection blood tests (MCEDs) that claim to screen for 50+ cancers with a single blood draw and promise peace of mind (i.e. Galleri & Cancerguard). We unpack why these tests are so compelling, what the marketing gets right (and what it leans on), and what it can feel like to navigate these conversations as patients and as primary care doctors. We also tease the key questions we think matter most—who might consider them, what happens after a “signal detected” result, and why this isn’t a simple yes/no situation in real life.  00:00 Podcast mission 01:13 Why this topic now 04:43 What these tests promise 05:50 Why it went viral 08:36 Marketing tactics 12:19 Cost and access 14:05 How the test works 18:01 Scary stats vs evidence 19:45 Does it detect cancer 21:04 Sensitivity specificity explained 23:32 Predictive value reality check 25:55 Explaining False Positives 26:41 Why It Cannot Replace Screening 28:12 Pathfinder Study Setup 31:24 Pathfinder Results Breakdown 32:40 Workup Cascade And Harms 36:00 Insurance And Downstream Costs 37:23 NHS Trial Early Signals 40:55 Guidelines And Shared Decisions 44:15 When Doctors Might Use It 49:23 Final Takeaways And Wrap 50:01 Podcast Medical Disclaimer 📖 Read the full episode summary, sources, and resources on our Substack:  👉www.theantisocialdoctors.com

Episode 13: Are GLP-1s a Miracle, a Mistake, or Something More Complicated?

In this episode, we dive into the GLP-1 conversation that’s everywhere—between “miracle drug” hype, scary side-effect stories, and the stigma that comes with seeking help. We share the kind of patient scenario we’re seeing constantly, talk about why these meds went viral, and explore what often gets lost in online discourse: nuance, individualized risk/benefit decisions, and real informed consent. We also tease what we consider when someone has health anxiety, a history of disordered eating, or is getting information (or prescriptions) through less-regulated channels.  00:00 Podcast intro and mission 01:18 Patient story GLP-1 dilemma 03:23 Social media claims and stigma 06:29 Why GLP-1s went viral 12:06 Nugget of truth and nuance 13:51 What GLP-1 drugs are 17:57 Benefits beyond diabetes 23:57 Fatty liver and metabolism 28:37 Is weight loss a benefit 34:22 Weight Stigma in Care 35:53 When to Discuss Weight 37:46 Is Weight Loss a Benefit 39:05 BMI vs Metabolic Health 40:21 GLP-1 Weight Loss Data 43:31 Long-Term Outcomes Matter 44:53 Weight Cycling Risks 47:58 Other Potential Benefits 48:51 Common Side Effects 49:59 Muscle and Bone Loss 52:44 Cancer and Eye Concerns 56:13 Mental Health Signals 59:21 Telehealth Misuse Risks 01:02:45 Cost and Sustainability 01:05:23 Alternatives Like Metformin 01:06:29 Long-Term Treatment Reality 01:09:37 Undereating Risks 01:10:04 Early Intervention Debate 01:11:12 Biology Over Willpower 01:11:58 Environment Versus Meds 01:13:58 Weight Cycling Reality 01:15:31 Compounded GLP-1 Dangers 01:21:05 Informed Consent Lessons 01:22:42 Stigma and Patient Fears 01:27:08 Food Noise Explained 01:31:40 Fatphobia and Epigenetics 01:35:05 How We Counsel Patients 01:43:01 Resources and Disclaimer 📖 Read the full episode summary, sources, and resources on our Substack:  👉www.theantisocialdoctors.com

Episode 12: What's the Deal With Peptides?

In this episode, we dig into peptides—why they’re suddenly everywhere, why people are trying them, and why the online conversation often feels worlds apart from the medical one. We zoom out from the hype to explore what peptides actually are, why some have become blockbuster therapies, and how a mix of optimization culture, mistrust of institutions, and access issues has fueled a booming gray market. We also explore the key questions we think everyone should be asking before trying anything that’s framed as “natural,” “risk-free,” or “not really a drug,” and we discuss what this trend can teach us about informed consent, patient autonomy, and where medicine may be headed next. 00:00 Podcast intro 01:18 Meet the hosts 01:21 Peptides topic setup 02:01 Patient longevity story 03:39 Why peptides hype 05:11 Natural fallacy talk 06:50 What is a peptide 08:19 Peptide drugs history 10:47 Why peptides booming 12:06 Legal gray areas 13:55 Why it went viral 14:50 Optimization culture 16:35 Distrust and marketing 20:14 K shaped economy angle 24:37 Nugget of truth 26:44 Peptides are drugs 28:56 Gray market risks 31:30 Evidence categories 32:49 FDA approved examples 33:22 Immune booster peptide 34:14 Growth Hormone Peptides 35:00 Side Effects Reality Check 36:49 Statins Versus Hype 37:54 Retatrutide Triple Agonist 38:59 Wolverine Stack Breakdown 39:31 BPC 157 Claims 40:35 TB 500 No Human Data 43:17 Regulation Versus Wild West 45:11 Why Patients Take Risks 46:42 Doctoring With Empathy 50:26 Informed Consent Gaps 52:55 Framing Changes Decisions 55:39 Peptides Future Outlook 58:26 Fund Studies Faster 01:00:05 Wrap Up And Disclaimer 📖 Read the full episode summary, sources, and resources on our Substack:  👉www.theantisocialdoctors.com

Episode 11: How Much Protein Do We Really Need?

In this episode, we dive into the current obsession with protein—why it’s everywhere, why people feel pressure to hit high daily targets, and how even official messaging is fueling the conversation. We review what protein actually does, who may benefit from prioritizing it, why “more” isn’t always better, and how real-life constraints and the modern food environment may complicate the the outcomes of "eat more protein" messaging. 00:00 Podcast Mission Intro 01:19 Why Protein Is Everywhere 03:09 The Viral Protein Claim 04:24 How Protein Became Trendy 07:36 Optimization Culture and Inequality 10:45 New US Protein Guidelines 12:53 Protein Basics and Sarcopenia 15:02 Who Needs More Protein 16:10 How Much Americans Eat Now 18:54 Evidence Based Targets by Group 20:12 Lean Mass Caveat for Obesity 22:25 Why Protein Targets Creep Up 23:42 Who Actually Benefits 24:23 More Protein Without Training 26:39 Social Media Protein Hype 28:18 Plant Proteins Explained 29:57 Guidelines Graphic Critique 31:35 Protein Products and Marketing 33:39 When Supplements Make Sense 36:09 Barriers Beyond Willpower 37:33 Practical Takeaways and Trends 42:12 Resources and Wrap Up 42:48 Medical Disclaimer 📖 Read the full episode summary, sources, and resources on our Substack:  👉www.theantisocialdoctors.com